{"task_id": "74249d0b7414147c", "source": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf (Part 561/905)", "text": "xychloroquine/topical tacrolimus for skin disease.\n\n--- Page 567 ---\n553\nRheumatology\n\ue007Always interpret in the context of clinical \ufb01 ndings: Diff erent antibodies have \ndiff erent disease asssociations.\nRheumatological: Rheumatoid factor (RhF) positive in:\nSj\u00f6gren\u2019s syndrome\n\u2264100% Mixed connective tissue disease\n50%\nFelty\u2019s syndrome\n\u2264100% SLE\n\u226440%\nRA\n70% Systemic sclerosis\n30%\nInfection (SBE/IE; hepatitis)\n\u226450% Normal\n2\u201310%\nAnticyclic citrullinated peptide Ab (anti-CCP): \n5 rheumatoid arthritis (~96% speci\ufb01 city)\nAntinuclear antibody (ANA) positive by immuno\ufb02 uorescence in:\nSLE\n>95% Systemic sclerosis\n96%\nAutoimmune hepatitis\n75% RA\n30%\nSj\u00f6gren\u2019s syndrome\n68% Normal\n0\u20132%\nANA titres are expressed according to dilutions at which antibodies can be detected, ie \n1:160 means antibodies can still be detected after the serum has been diluted 160 times. \nTitres of 1:40 or 1:80 may not be signi\ufb01 cant. The pattern of staining may indicate the \ndisease (although these are not speci\ufb01 c):\n  \n\u2022 Homogeneous\nSLE\n  \n\u2022 Nucleolar\nSystemic sclerosis\n  \n\u2022 Speckled\nMixed CT disease\n  \n\u2022 Centromere Limited systemic sclerosis\nAnti-double-stranded DNA (dsDNA): SLE (60% sensitivity, but highly speci\ufb01 c).\nAntihistone Ab: drug-induced SLE (~100%).\nAntiphospholipid Ab (eg anti-cardiolipin Ab): antiphospholipid syndrome, SLE.\nAnticentromere Ab: limited systemic sclerosis.\nAnti-extractable nuclear antigen (ENA) antibodies (usually with +ve ANA):\n  \n\u2022 Anti-Ro (SSA)\nSLE, Sj\u00f6gren\u2019s syndrome, systemic sclerosis. \nAssociated with congenital heart block.\n  \n\u2022 Anti-La (SSB)\nSj\u00f6gren\u2019s syndrome, SLE (15%).\n  \n\u2022 Anti-Sm\nSLE (20\u201330%).\n  \n\u2022 Anti-RNP\nSLE, mixed connective tissue disease.\n  \n\u2022 Anti Jo-1; Anti-Mi-2\nPolymyositis, dermatomyositis.\n  \n\u2022 Anti-Scl70\nDiff use systemic sclerosis.\nGastrointestinal: (For liver autoantibodies, see p284.)\nAntimitochondrial Ab (AMA): primary biliary cholangitis (>95%), autoimmune \nhepatitis (30%), idiopathic cirrhosis (25\u201330%).\nAnti-smooth muscle Ab (SMA): autoimmune hepatitis (70%), primary biliary chol-\nangitis (50%), idiopathic cirrhosis (25\u201330%).\nGastric parietal cell Ab: pernicious anaemia (>90%), atrophic gastritis (40%), \n\u2018normal\u2019 (10%).\nIntrinsic factor Ab: pernicious anaemia (50%).\n\ue025-gliadin Ab, antitissue transglutaminase, anti-endomysial Ab: coeliac disease.\nEndocrine: Thyroid peroxidase Ab: Hashimoto\u2019s thyroiditis (~87%), Graves\u2019 \n(>50%). Islet cell Ab (ICA), glutamic acid decarboxylase (GAD) Ab: type 1 diabetes \nmellitus (75%).\nRenal: Glomerular basement membrane Ab (anti-GBM): Goodpasture\u2019s disease (100%).\nAntineutrophil cytoplasmic Ab (ANCA):\n  \n\u2022 Cytoplasmic (cANCA), speci\ufb01 c for serine proteinase-3 (PR3 +ve). Granulo matosis \nwith polyangiitis (Wegener\u2019s) (90%); also microscopic polyangiitis (30%), pol-\nyarteritis nodosa (11%).\n  \n\u2022 Perinuclear (pANCA), speci\ufb01 c for myeloperoxidase (MPO +ve). Microscopic poly-\nangiitis (45%), Churg\u2013Strauss, pulmonary-renal vasculitides (Goodpasture\u2019s).\nUnlike immune-complex vasculitis, in ANCA-associated vasculitis no comp lement \nconsumption or immune complex deposition occurs (ie pauci-immune vasculitis). 42\nANCA may also be +ve in UC/Crohn\u2019s, sclerosing cholangitis, auto immune hepatitis, \nFelty\u2019s, RA, SLE, or drugs (eg antithyroid, allopurinol, cipro\ufb02 oxacin).\nNeurological: Acetylcholine receptor Ab: myasthenia gravis (90%)(see p512).\nAnti-voltage-gated K \n+-channel Ab: limbic encephalitis.\nAnti-voltage-gated Ca \n2+-channel Ab: Lambert\u2013Eaton syndrome (see p512).\nAnti-aquaporin 4: neuromyelitis optica (Devic\u2019s disease, p698).\nPlasma autoantibodies (Abs): disease associations\n5 Most centres now use anti-CCP antibodies for the initial workup of suspected RA.", "text_length": 3669, "metadata": {"source": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf (Part 561/905)", "type": "chunk", "chunk_index": 560, "total_chunks": 905, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T17:59:53.141386", "document_uuid": "1c4b3c41-9a74-4d3d-ab11-d2a041c9641f", "filename": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf", "category": "medical_pdf", "section": "body", "year": 2017, "outdated": false, "document_id": "1c4b3c41-9a74-4d3d-ab11-d2a041c9641f"}, "created_at": "2025-12-11T17:59:53.142315", "status": "complete", "chunks_added": 2}